SignatureFD’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
MSCM
ACA
RW
SignatureFD's IHE Position: Q2 2024 in Review
SignatureFD sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2024, closing a stake of 60 shares — an estimated $4.07K sold.
SignatureFD first reported a position in IHE in Q3 2016 and held it in 25 quarters. The position peaked at $10K in Q2 2022. 143 funds tracked by Wall St. Rank hold IHE as of Q2 2024.
- SignatureFD reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
- SignatureFD sold 60 iShares US Pharmaceuticals ETF shares in Q2 2024, an estimated $4.07K.
- SignatureFD first reported a position in iShares US Pharmaceuticals ETF in Q3 2016 and held it in 25 quarters.
- SignatureFD's iShares US Pharmaceuticals ETF position peaked at $10K in Q2 2022.
- 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2024.
Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.